IP Library › Granted Patent US 8,460,458
Granted Patent B2
US 8,460,458 · App. 13/452,524 · Granted Jun 11, 2013

Healing agent in cement-based materials and structures, and process for its preparation

Inventor: Hendrik Marius Jonkers (Delfgauw, NL)
Assignee: Technische Universiteit Delft
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,460,458
App. No.
13/452,524
Granted
Jun 11, 2013
Kind
B2
Abstract

A process for the preparation of the healing agent in cement-based materials and structures, wherein said healing agent comprises organic compounds and/or bacteria-loaded porous particles, which porous particles comprise expanded clay- or sintered fly-ash. Furthermore, said porous particles are intact spheres, broken or crushed particles derived from said intact spheres, having a specific density between 0.4 and 2 g cm −3 .

Claims (17)

1. A process to decrease permeability of cracked concrete, the process comprising:

providing a healing agent wherein said healing agent comprises either porous particles loaded with bacterial spores and organic compounds or a combination of a first set of porous particles loaded with bacterial spores and a second set of porous particles loaded with organic compounds;

adding said healing agent to concrete; and

activating the healing agent with water.

2. The process according to claim 1 , wherein said porous particles comprise expanded clay or sintered fly ash.

3. The process according to claim 1 , wherein said porous particles are intact spheres or broken or crushed particles derived from said intact spheres.

4. The process according to claim 1 , wherein the specific density of said porous particles is between 0.4 and 2 g cm −3 .

5. The process according to claim 1 , wherein the surface pores have a width of 0.01 to 100 μm.

6. The process according to claim 5 , wherein the surface pores have a width of 0.01 and 15 μm.

7. The process according to claim 1 , wherein the particles of the first set have a diameter of >=0.02 mm.

8. The process according to claim 7 , wherein the porous particles of the first set have a diameter of 0.02 mm to 8 mm.

9. The process according to claim 8 , wherein the porous particles of the first set have a diameter of 0.05 mm to 1.0 mm and surface pores with a width of 1.0 to 15 μm.

10. The process according to claim 1 , wherein said bacterial spores belong to the genera Bacillus or Sporosarcina and comprise either vegetative bacteria or their spores or a combination of the two.

11. The process according to claim 10 , wherein the bacterial spores are of Bacillus pseudofirmus or Sporosarcina pasteurii.

12. The process according to claim 1 , wherein the organic compounds comprise an organic biomineral precursor compound and organic bacterial growth factors.

13. The process according to claim 12 , wherein the organic biomineral precursor compound comprises an organic calcium or sodium salt and the organic bacterial growth factors comprise yeast extract or peptone.

14. The process according to claim 1 , wherein the particle surface pore width is 0.01-1 μm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2018
From: TECHNISCHE UNIVERSITEIT DELFT
To: GREEN-BASILISK B.V.
Reel/Frame 046506/0943 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2012
From: JONKERS, HENDRIK M.
To: TECHNISCHE UNIVERSITEIT DELFT
Reel/Frame 028280/0077 →
Priority Claims (1)
EP 08100833 · Jan 23, 2008 · regional
Continuity (3)
Division 12841581 · Jul 22, 2010
Continuation PCTNL2009050025 · Jan 22, 2009
Related Publication 20120199046A1 · Aug 9, 2012